Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review.

Sato Y, Watanabe K, Matsuoka M, Yamada Y, Yagi K, Sunami K, Ogawa M, Oda K, Baba Y

DOI: 10.1007/s12029-026-01561-4
Published: 2026 Aug 7
Container: Journal of gastrointestinal cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12029-026-01561-4,
  title = {Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review.},
  author = {Sato Y and Watanabe K and Matsuoka M and Yamada Y and Yagi K and Sunami K and Ogawa M and Oda K and Baba Y},
  year = {2026},
  journal = {Journal of gastrointestinal cancer},
  doi = {10.1007/s12029-026-01561-4},
  url = {https://doi.org/10.1007/s12029-026-01561-4}
}

RIS

TY  - JOUR
TI  - Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review.
AU  - Sato Y
AU  - Watanabe K
AU  - Matsuoka M
AU  - Yamada Y
AU  - Yagi K
AU  - Sunami K
AU  - Ogawa M
AU  - Oda K
AU  - Baba Y
PY  - 2026
JO  - Journal of gastrointestinal cancer
DO  - 10.1007/s12029-026-01561-4
UR  - https://doi.org/10.1007/s12029-026-01561-4
ER  -

APA

Y, S., K, W., M, M., Y, Y., K, Y., K, S., M, O., K, O., & Y, B. (2026). Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review.. Journal of gastrointestinal cancer. https://doi.org/10.1007/s12029-026-01561-4

Source records

pubmed · retrieved 2026-09-26T03:21:15.113Z